Reviewed,
UniProtKB/Swiss-Prot P08670 (VIME_HUMAN)
Last modified
June 16, 2009.
Version 132.
History...
Clusters with 100%,
90%,
50% identity |
Documents (4) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Vimentin | ||
| Gene names |
| ||
| Organism | Homo sapiens (Human) | ||
| Taxonomic identifier | 9606 [NCBI] | ||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 466 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | Vimentins are class-III intermediate filaments found in various non-epithelial cells, especially mesenchymal cells. |
| Subunit structure | Homopolymer. Interacts with HCV core protein. Interacts with LGSN and SYNM By similarity. |
| Tissue specificity | Highly expressed in fibroblasts, some expression in T- and B-lymphocytes, and little or no expression in Burkitt's lymphoma cell lines. Expressed in many hormone-independent mammary carcinoma cell lines. Ref.12 Ref.16 |
| Post-translational modification | One of the most prominent phosphoproteins in various cells of mesenchymal origin. Phosphorylation is enhanced during cell division, at which time vimentin filaments are significantly reorganized. |
| Sequence similarities | Belongs to the intermediate filament family. |
| Sequence caution | The sequence BAB71275.1 differs from that shown. Reason: Miscellaneous discrepancy. Intron retention. |
Ontologies
| Keywords | |
|---|---|
| Biological process | Host-virus interaction |
| Cellular component | Intermediate filament |
| Domain | Coiled coil |
| PTM | Acetylation Phosphoprotein |
| Technical term | 3D-structure Direct protein sequencing |
| Gene Ontology (GO) | |
| Biological process | cell motion Traceable author statement. Source: UniProtKB interspecies interaction between organismsInferred from electronic annotation. Source: UniProtKB-KW |
| Cellular component | cytoplasm Ref.14 Inferred from direct assay. Source: UniProtKB intermediate filament Ref.32Inferred from direct assay. Source: UniProtKB |
| Molecular function | protein binding Ref.32 Inferred from direct assay. Source: UniProtKB structural constituent of cytoskeleton Ref.32Inferred from direct assay. Source: UniProtKB |
| Complete GO annotation... | |
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| itself | 2 | EBI-353844,EBI-353844 | ||
| CRMP1 | Q14194 | 1 | EBI-353844,EBI-473101 | |
| MDM2 | Q00987 | 1 | EBI-353844,EBI-389668 | |
| MYST2 | O95251 | 2 | EBI-353844,EBI-473199 |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||
Molecule processing | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Initiator methionine | 1 | 1 | Removed Ref.13 | ||||||||||
| Chain | 2 – 466 | 465 | Vimentin | PRO_0000063754 | |||||||||
Regions | |||||||||||||
| Region | 2 – 95 | 94 | Head | ||||||||||
| Region | 96 – 407 | 312 | Rod | ||||||||||
| Region | 96 – 131 | 36 | Coil 1A | ||||||||||
| Region | 132 – 153 | 22 | Linker 1 | ||||||||||
| Region | 154 – 245 | 92 | Coil 1B | ||||||||||
| Region | 246 – 268 | 23 | Linker 12 | ||||||||||
| Region | 269 – 407 | 139 | Coil 2 | ||||||||||
| Region | 408 – 466 | 59 | Tail | ||||||||||
Amino acid modifications | |||||||||||||
| Modified residue | 2 | 1 | N-acetylserine Ref.13 | ||||||||||
| Modified residue | 5 | 1 | Phosphoserine Ref.18 Ref.29 | ||||||||||
| Modified residue | 7 | 1 | Phosphoserine; by PKA and PKC Ref.18 | ||||||||||
| Modified residue | 8 | 1 | Phosphoserine Ref.18 | ||||||||||
| Modified residue | 9 | 1 | Phosphoserine; by PKC Ref.18 | ||||||||||
| Modified residue | 10 | 1 | Phosphoserine; by PKC Ref.18 | ||||||||||
| Modified residue | 25 | 1 | Phosphoserine; by PKA and PKC By similarity | ||||||||||
| Modified residue | 26 | 1 | Phosphoserine; by PKC By similarity | ||||||||||
| Modified residue | 27 | 1 | Phosphoserine Ref.21 | ||||||||||
| Modified residue | 34 | 1 | Phosphoserine Ref.29 | ||||||||||
| Modified residue | 38 | 1 | Phosphotyrosine Ref.24 | ||||||||||
| Modified residue | 39 | 1 | Phosphoserine; by CaMK2, PKA and PKC Ref.18 Ref.29 Ref.26 | ||||||||||
| Modified residue | 42 | 1 | Phosphoserine; by PKC Ref.18 Ref.29 | ||||||||||
| Modified residue | 47 | 1 | Phosphoserine Ref.26 | ||||||||||
| Modified residue | 49 | 1 | Phosphoserine By similarity | ||||||||||
| Modified residue | 51 | 1 | Phosphoserine; by PKA and PKC By similarity | ||||||||||
| Modified residue | 53 | 1 | Phosphotyrosine Ref.24 | ||||||||||
| Modified residue | 55 | 1 | Phosphoserine Ref.26 | ||||||||||
| Modified residue | 56 | 1 | Phosphoserine Ref.29 Ref.21 Ref.26 Ref.22 Ref.23 Ref.25 Ref.28 | ||||||||||
| Modified residue | 61 | 1 | Phosphotyrosine Ref.29 Ref.24 Ref.26 | ||||||||||
| Modified residue | 66 | 1 | Phosphoserine; by PKA and PKC By similarity | ||||||||||
| Modified residue | 72 | 1 | Phosphoserine Ref.18 Ref.29 | ||||||||||
| Modified residue | 73 | 1 | Phosphoserine Ref.18 Ref.29 Ref.21 | ||||||||||
| Modified residue | 83 | 1 | Phosphoserine Ref.29 | ||||||||||
| Modified residue | 117 | 1 | Phosphotyrosine Ref.24 Ref.19 | ||||||||||
| Modified residue | 144 | 1 | Phosphoserine Ref.29 | ||||||||||
| Modified residue | 214 | 1 | Phosphoserine Ref.21 | ||||||||||
| Modified residue | 226 | 1 | Phosphoserine Ref.29 | ||||||||||
| Modified residue | 299 | 1 | Phosphoserine Ref.29 | ||||||||||
| Modified residue | 409 | 1 | Phosphoserine Ref.29 | ||||||||||
| Modified residue | 412 | 1 | Phosphoserine Ref.29 Ref.21 Ref.25 Ref.28 Ref.27 | ||||||||||
| Modified residue | 419 | 1 | Phosphoserine By similarity | ||||||||||
| Modified residue | 420 | 1 | Phosphoserine Ref.18 | ||||||||||
| Modified residue | 430 | 1 | Phosphoserine Ref.18 Ref.26 | ||||||||||
| Modified residue | 446 | 1 | Phosphothreonine Ref.25 | ||||||||||
| Modified residue | 458 | 1 | Phosphothreonine Ref.18 Ref.26 | ||||||||||
| Modified residue | 459 | 1 | Phosphoserine Ref.18 Ref.29 Ref.26 Ref.25 Ref.28 | ||||||||||
Experimental info | |||||||||||||
| Sequence conflict | 39 – 50 | 12 | Missing in BAB71275. Ref.5 | ||||||||||
| Sequence conflict | 42 | 1 | S → D in AAA61279. Ref.1 | ||||||||||
| Sequence conflict | 68 – 76 | 9 | Missing in BAB71275. Ref.5 | ||||||||||
| Sequence conflict | 113 | 1 | R → P in CAA34499. Ref.12 | ||||||||||
| Sequence conflict | 197 | 1 | E → G in CAG28618. Ref.6 | ||||||||||
| Sequence conflict | 201 | 1 | N → S in AAA61281. Ref.16 | ||||||||||
| Sequence conflict | 265 | 1 | L → S in AAA61281. Ref.16 | ||||||||||
| Sequence conflict | 278 | 1 | S → I in AAA61281. Ref.16 | ||||||||||
| Sequence conflict | 339 | 1 | S → C in AAA61281. Ref.16 | ||||||||||
| Sequence conflict | 350 | 1 | N → K in AAA61281. Ref.16 | ||||||||||
| Sequence conflict | 442 | 1 | L → F in AAA61279. Ref.1 | ||||||||||
Secondary structure | |||||||||||||
Helix Strand Turn | |||||||||||||
| Helix | 102 – 135 | 34 | |||||||||||
| Helix | 329 – 404 | 76 | |||||||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Coding sequence and growth regulation of the human vimentin gene." Ferrari S., Battini R., Kaczmarek L., Rittling S., Calabretta B., de Riel J.K., Philiponis V., Wei J.-F., Baserga R. Mol. Cell. Biol. 6:3614-3620(1986) [PubMed: 3467175] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]. |
| [2] | "Nucleotide sequence of cDNA covering the complete coding part of the human vimentin gene." Honore B., Madsen P., Basse B., Andersen A., Walbum E., Celis J.E., Leffers H. Nucleic Acids Res. 18:6692-6692(1990) [PubMed: 2251132] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. |
| [3] | "SEREX identification of new tumour-associated antigens in cutaneous T-cell lymphoma." Hartmann T.B., Thiel D., Dummer R., Schadendorf D., Eichmueller S. Br. J. Dermatol. 150:252-258(2004) [PubMed: 14996095] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. Tissue: Lymphoma. |
| [4] | Zimbelmann R. Submitted (JUN-2007) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [MRNA]. Tissue: Testis. |
| [5] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed: 14702039] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Embryo, Placenta and Stomach. |
| [6] | "Cloning of human full open reading frames in Gateway(TM) system entry vector (pDONR201)." Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B. Submitted (MAY-2004) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. |
| [7] | Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S. Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Adipose tissue and Coronary artery. |
| [8] | NHLBI resequencing and genotyping service (RS&G) Submitted (FEB-2007) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]. |
| [9] | "The DNA sequence and comparative analysis of human chromosome 10." Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L., Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K., Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L., Taylor A., Battles J. Rogers J.Nature 429:375-381(2004) [PubMed: 15164054] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [10] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [11] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Cervix, Placenta and Testis. |
| [12] | "Vimentin rather than keratin expression in some hormone-independent breast cancer cell lines and in oncogene-transformed mammary epithelial cells." Sommers C.L., Walker-Jones D., Heckford S.E., Worland P., Valverius E., Clark R., McCormick F., Stampfer M., Abularach S., Gelmann E.P. Cancer Res. 49:4258-4263(1989) [PubMed: 2472876] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 1-135, TISSUE SPECIFICITY. Tissue: Mammary carcinoma. |
| [13] | Bienvenut W.V., Kanor S., Tissot J.-D., Quadroni M. Submitted (MAY-2006) to UniProtKB Cited for: PROTEIN SEQUENCE OF 2-11; 87-96; 129-138; 188-195; 223-234; 282-291; 322-333 AND 381-389, CLEAVAGE OF INITIATOR METHIONINE, ACETYLATION AT SER-2, MASS SPECTROMETRY. Tissue: T-cell. |
| [14] | "Two-dimensional electrophoretic analysis of human breast carcinoma proteins: mapping of proteins that bind to the SH3 domain of mixed lineage kinase MLK2." Rasmussen R.K., Ji H., Eddes J.S., Moritz R.L., Reid G.E., Simpson R.J., Dorow D.S. Electrophoresis 18:588-598(1997) [PubMed: 9150946] [Abstract] Cited for: PROTEIN SEQUENCE OF 17-25 AND 55-70. Tissue: Mammary carcinoma. |
| [15] | Lubec G., Vishwanath V., Chen W.-Q., Sun Y. Submitted (DEC-2008) to UniProtKB Cited for: PROTEIN SEQUENCE OF 51-64; 79-97; 105-113; 130-139; 146-155; 176-184; 189-207; 223-235; 283-292; 295-304; 322-334; 346-373; 382-401 AND 411-439, MASS SPECTROMETRY. Tissue: Brain, Cajal-Retzius cell and Fetal brain cortex. |
| [16] | "Nucleotide sequence of the human vimentin gene and regulation of its transcription in tissues and cultured cells." Perreau J., Lilienbaum A., Vasseur M., Paulin D. Gene 62:7-16(1988) [PubMed: 3371665] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 113-466, TISSUE SPECIFICITY. Tissue: Fibroblast. |
| [17] | "Isolation of a human vimentin cDNA with a long 3'-noncoding region from a human osteosarcoma cell line (MG-63)." Gupta A.K., Aubin J.E., Waye M.M.Y. Gene 86:303-304(1990) [PubMed: 2323579] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 167-466. Tissue: Osteosarcoma. |
| [18] | "Specific in vivo phosphorylation sites determine the assembly dynamics of vimentin intermediate filaments." Eriksson J.E., He T., Trejo-Skalli A.V., Harmala-Brasken A.-S., Hellman J., Chou Y.-H., Goldman R.D. J. Cell Sci. 117:919-932(2004) [PubMed: 14762106] [Abstract] Cited for: PHOSPHORYLATION AT SER-5; SER-7; SER-8; SER-9; SER-10; SER-39; SER-42; SER-72; SER-73; SER-420; SER-430; THR-458 AND SER-459, MASS SPECTROMETRY. |
| [19] | "Immunoaffinity profiling of tyrosine phosphorylation in cancer cells." Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H., Zha X.-M., Polakiewicz R.D., Comb M.J. Nat. Biotechnol. 23:94-101(2005) [PubMed: 15592455] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-117, MASS SPECTROMETRY. |
| [20] | "Proteomic profiling of cellular proteins interacting with the hepatitis C virus core protein." Kang S.-M., Shin M.-J., Kim J.-H., Oh J.-W. Proteomics 5:2227-2237(2005) [PubMed: 15846844] [Abstract] Cited for: INTERACTION WITH HCV CORE PROTEIN. |
| [21] | "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks." Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M. Cell 127:635-648(2006) [PubMed: 17081983] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-27; SER-56; SER-73; SER-214 AND SER-412, MASS SPECTROMETRY. Tissue: Epithelium. |
| [22] | "A probability-based approach for high-throughput protein phosphorylation analysis and site localization." Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P. Nat. Biotechnol. 24:1285-1292(2006) [PubMed: 16964243] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-56, MASS SPECTROMETRY. Tissue: Epithelium. |
| [23] | "Phosphoproteome analysis of the human mitotic spindle." Nousiainen M., Sillje H.H.W., Sauer G., Nigg E.A., Koerner R. Proc. Natl. Acad. Sci. U.S.A. 103:5391-5396(2006) [PubMed: 16565220] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-56, MASS SPECTROMETRY. Tissue: Epithelium. |
| [24] | "Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer." Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J., Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L., Mitchell J., Wetzel R., Macneill J., Ren J.M. Comb M.J.Cell 131:1190-1203(2007) [PubMed: 18083107] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-38; TYR-53; TYR-61 AND TYR-117, MASS SPECTROMETRY. |
| [25] | "Improved titanium dioxide enrichment of phosphopeptides from HeLa cells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra." Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D. J. Proteome Res. 6:4150-4162(2007) [PubMed: 17924679] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-56; SER-412; THR-446 AND SER-459, MASS SPECTROMETRY. Tissue: Epithelium. |
| [26] | "Global proteomic profiling of phosphopeptides using electron transfer dissociation tandem mass spectrometry." Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A. Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007) [PubMed: 17287340] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-39; SER-47; SER-55; SER-56; TYR-61; SER-430; THR-458 AND SER-459, MASS SPECTROMETRY. |
| [27] | "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis." Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III J. Proteome Res. 7:1346-1351(2008) [PubMed: 18220336] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-51 AND SER-412, MASS SPECTROMETRY. |
| [28] | "Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle." Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R., Greff Z., Keri G., Stemmann O., Mann M. Mol. Cell 31:438-448(2008) [PubMed: 18691976] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-56; SER-412 AND SER-459, MASS SPECTROMETRY. |
| [29] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed: 18669648] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-5; SER-25; SER-34; SER-39; SER-42; SER-51; SER-56; TYR-61; SER-72; SER-73; SER-83; SER-144; SER-226; SER-299; SER-409; SER-412 AND SER-459, MASS SPECTROMETRY. |
| [30] | Colinge J., Superti-Furga G., Bennett K.L. Submitted (OCT-2008) to UniProtKB Cited for: IDENTIFICATION [LARGE SCALE ANALYSIS], MASS SPECTROMETRY. |
| [31] | "Divide-and-conquer crystallographic approach towards an atomic structure of intermediate filaments." Strelkov S.V., Herrmann H., Geisler N., Lustig A., Ivaninskii S., Zimbelmann R., Burkhard P., Aebi U. J. Mol. Biol. 306:773-781(2001) [PubMed: 11243787] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (1.4 ANGSTROMS) OF 102-138. |
| [32] | "Conserved segments 1A and 2B of the intermediate filament dimer: their atomic structures and role in filament assembly." Strelkov S.V., Herrmann H., Geisler N., Wedig T., Zimbelmann R., Aebi U., Burkhard P. EMBO J. 21:1255-1266(2002) [PubMed: 11889032] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (1.4 ANGSTROMS) OF 103-139 AND 328-411. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M14144 Genomic DNA. Translation: AAA61279.1. X56134 mRNA. Translation: CAA39600.1. AF328728 mRNA. Translation: AAN09720.1. Z19554 mRNA. Translation: CAA79613.2. AK056766 mRNA. Translation: BAB71275.1. Frameshift. AK097336 mRNA. Translation: BAC05002.1. AK290643 mRNA. Translation: BAF83332.1. CR407690 mRNA. Translation: CAG28618.1. AK222507 mRNA. Translation: BAD96227.1. AK222602 mRNA. Translation: BAD96322.1. EF445046 Genomic DNA. Translation: ACA06101.1. EF445046 Genomic DNA. Translation: ACA06102.1. AL133415 Genomic DNA. Translation: CAB87963.1. CH471072 Genomic DNA. Translation: EAW86215.1. BC000163 mRNA. Translation: AAH00163.2. BC030573 mRNA. Translation: AAH30573.1. BC066956 mRNA. Translation: AAH66956.1. X16478 mRNA. Translation: CAA34499.1. M18895 M18894 Genomic DNA. Translation: AAA61281.2. M25246 mRNA. Translation: AAA61282.1. | |||||||||||||||||||||||||||||||
| IPI | IPI00418471. | ||||||||||||||||||||||||||||||
| PIR | A25074. S13115. | ||||||||||||||||||||||||||||||
| RefSeq | NP_003371.2. | ||||||||||||||||||||||||||||||
| UniGene | Hs.642813 | ||||||||||||||||||||||||||||||
3D structure databases | |||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||||||||||||||
Protein-protein interaction databases | |||||||||||||||||||||||||||||||
| IntAct | P08670. 86 interactions. | ||||||||||||||||||||||||||||||
PTM databases | |||||||||||||||||||||||||||||||
| PhosphoSite | P08670. | ||||||||||||||||||||||||||||||
2-D gel databases | |||||||||||||||||||||||||||||||
| SWISS-2DPAGE | P08670. | ||||||||||||||||||||||||||||||
| Aarhus/Ghent-2DPAGE | 8417. IEF. | ||||||||||||||||||||||||||||||
| Cornea-2DPAGE | P08670. | ||||||||||||||||||||||||||||||
| DOSAC-COBS-2DPAGE | P08670. | ||||||||||||||||||||||||||||||
| HSC-2DPAGE | P08670. | ||||||||||||||||||||||||||||||
| OGP | P08670. | ||||||||||||||||||||||||||||||
| PHCI-2DPAGE | P08670. | ||||||||||||||||||||||||||||||
| REPRODUCTION-2DPAGE | IPI00418471. P08670. | ||||||||||||||||||||||||||||||
Proteomic databases | |||||||||||||||||||||||||||||||
| PeptideAtlas | P08670. | ||||||||||||||||||||||||||||||
| PRIDE | P08670. | ||||||||||||||||||||||||||||||
Genome annotation databases | |||||||||||||||||||||||||||||||
| Ensembl | ENSG00000026025. Homo sapiens. [Contig view] | ||||||||||||||||||||||||||||||
| GeneID | 7431. | ||||||||||||||||||||||||||||||
| KEGG | hsa:7431. | ||||||||||||||||||||||||||||||
Organism-specific databases | |||||||||||||||||||||||||||||||
| GeneCards | GC10P017310. | ||||||||||||||||||||||||||||||
| H-InvDB | HIX0008682. HIX0035657. | ||||||||||||||||||||||||||||||
| HGNC | HGNC:12692. VIM. | ||||||||||||||||||||||||||||||
| HPA | CAB000080. HPA001762. | ||||||||||||||||||||||||||||||
| MIM | 193060. gene. | ||||||||||||||||||||||||||||||
| PharmGKB | PA37311. | ||||||||||||||||||||||||||||||
| GenAtlas | Search... | ||||||||||||||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||||||||||||||
| HOVERGEN | P08670. | ||||||||||||||||||||||||||||||
| OMA | P08670. ANRTNEK. | ||||||||||||||||||||||||||||||
Enzyme and pathway databases | |||||||||||||||||||||||||||||||
| Pathway_Interaction_DB | aurora_b_pathway. Aurora B signaling. caspase_pathway. Caspase cascade in apoptosis. | ||||||||||||||||||||||||||||||
| Reactome | REACT_578. Apoptosis. | ||||||||||||||||||||||||||||||
Gene expression databases | |||||||||||||||||||||||||||||||
| ArrayExpress | P08670. | ||||||||||||||||||||||||||||||
| Bgee | P08670. | ||||||||||||||||||||||||||||||
| GermOnline | ENSG00000026025. Homo sapiens. | ||||||||||||||||||||||||||||||
Family and domain databases | |||||||||||||||||||||||||||||||
| InterPro | IPR016044. F. IPR001664. IF. IPR006821. Intermed_filament_DNA_bd. IPR018039. Intermediate_filament_CS. [Graphical view] | ||||||||||||||||||||||||||||||
| PANTHER | PTHR23239. IF. 1 hit. | ||||||||||||||||||||||||||||||
| Pfam | PF00038. Filament. 1 hit. PF04732. Filament_head. 1 hit. [Graphical view] | ||||||||||||||||||||||||||||||
| PROSITE | PS00226. IF. 1 hit. [Graphical view] | ||||||||||||||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||||||||||||||
Other Resources | |||||||||||||||||||||||||||||||
| NextBio | 29104. | ||||||||||||||||||||||||||||||
| PMAP-CutDB | P08670. | ||||||||||||||||||||||||||||||
| SOURCE | Search... | ||||||||||||||||||||||||||||||
Entry information
| Entry name | VIME_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P08670 Secondary accession number(s): B0YJC2 Q9NTM3 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation project | HPI (Human Proteome Initiative) | ||||||||
Relevant documents
| Human chromosome 10 Human chromosome 10: entries, gene names and cross-references to MIM |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with


